Literature DB >> 15325851

Erythrocyte osmotic fragility test for screening of alpha-thalassemia-1 and beta-thalassemia trait in pregnancy.

S Sirichotiyakul1, C Tantipalakorn, T Sanguansermsri, C Wanapirak, T Tongsong.   

Abstract

OBJECTIVES: To evaluate the sensitivity and specificity of osmotic fragility test (OFT) as a screening test in predicting the severe thalassemia trait (alpha-thalassemia-1 & beta-thalassemia).
METHODS: A descriptive analysis and diagnostic test of non-anemic pregnant women attending antenatal care clinic, Maharaj Nakorn Chiang Mai, during April, and July 2002 was made. Blood samples were collected from 446 singleton pregnancies with no obvious medical complication such as iron deficiency anemia. OFT was performed in the same day, using 0.45% glycerin saline solution and the cut-off value of less than 60% was used for an abnormal test. Quantitative HbA2 test and PCR (SEA type) were done as a gold standard to confirm the diagnosis of beta-thalassemia trait and alpha-thalassemia-1 trait, respectively.
RESULTS: The main outcome measures were sensitivity, specificity, positive and negative predictive value of OFT. If the OFT cut-off value of less than 60% was considered positive, the test had a sensitivity, specificity, positive and negative predictive value of 97.6%, 72.9%, 33.6%, and 99.5%, respectively.
CONCLUSION: OFT has high sensitivity in detection of alpha-thalassemia-1 trait or beta-thalassemia trait and due to its simplicity with very low cost it may, therefore, be considered as a screening test in a wide population. Copyright 2004 International Federation of Gynecology and Obstetrics

Entities:  

Mesh:

Year:  2004        PMID: 15325851     DOI: 10.1016/j.ijgo.2004.04.037

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  8 in total

1.  Fetal anaemia from red blood cell membrane defect and co-inherited haemoglobin Constant Spring.

Authors:  Kasemsri Srisupundit; Pimlak Charoenkwan; Kuntharee Traisrisilp; Theera Tongsong
Journal:  BMJ Case Rep       Date:  2015-07-27

2.  Development of an ELISA strip for the detection of alpha thalassemias.

Authors:  Luksana Makonkawkeyoon; Somphon Pharephan; Pannee Sirivatanapa; Wirote Tuntiwechapikul; Sanit Makonkawkeyoon
Journal:  Haematologica       Date:  2009-10-22       Impact factor: 9.941

3.  NESTROFT - A Valuable, Cost Effective Screening Test for Beta Thalassemia Trait in North Indian Punjabi Population.

Authors:  Sanjay Piplani; Rahul Manan; Monika Lalit; Mridu Manjari; Tajinder Bhasin; Jasmine Bawa
Journal:  J Clin Diagn Res       Date:  2013-11-20

Review 4.  Epistasis and the sensitivity of phenotypic screens for beta thalassaemia.

Authors:  Bridget S Penman; Sunetra Gupta; David J Weatherall
Journal:  Br J Haematol       Date:  2014-12-17       Impact factor: 6.998

5.  Prevalence of α-thalassaemia genotypes in pregnant women in northern Thailand.

Authors:  Somphon Pharephan; Pannee Sirivatanapa; Sanit Makonkawkeyoon; Wirote Tuntiwechapikul; Luksana Makonkawkeyoon
Journal:  Indian J Med Res       Date:  2016-03       Impact factor: 2.375

6.  NESTROFT-A Cost-Effective Mass Screening Tool for the Detection of β-Thalassemia Carrier Status in Anemic Pregnant Women: A Step Toward Reducing the National Disease Burden.

Authors:  Manasi Gosavi; Ramesh Chavan; M B Bellad
Journal:  J Lab Physicians       Date:  2021-07-09

7.  Use of glucometer and fasting blood glucose as screening tools for diabetes mellitus type 2 and glycated haemoglobin as clinical reference in rural community primary care settings of a middle income country.

Authors:  Benja Muktabhant; Pattara Sanchaisuriya; Pongdech Sarakarn; Worawitaya Tawityanon; Mantana Trakulwong; Songsri Worawat; Frank P Schelp
Journal:  BMC Public Health       Date:  2012-05-14       Impact factor: 3.295

8.  Hemolysis area: A new parameter of erythrocyte osmotic fragility for screening of thalassemia trait.

Authors:  Thanusak Tatu; Denis Sweatman
Journal:  J Lab Physicians       Date:  2018 Apr-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.